JP Morgan Initiates Coverage on Tango Therapeutics, Inc. (TNGX) with Overweight
Rating Change JP Morgan analysts initiated coverage on Tango Therapeutics, Inc. (NASDAQ:TNGX) with a Overweight rating on July 15, 2026. Market Context Tango Therapeutics, Inc.
Read more
